Form D · Biotechnology
Aulos Bioscience, Inc.
Larkspur, CA · CIK 0001832335
Offering snapshot reported Aug 10, 2023 · SEC filing
- Reported sold
- $5M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 28, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2023 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Nov 16, 2020 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-489397
Source: Form D, filed Aug 10, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yechezkel Barenholz | Director |
| Anna Batarina | Director |
| Rajesh Chopra | Director |
| Michael Ehlers | Director |
| Seth Harrison | Director |
| Aron Knickerbocker | Director, Executive |
| Yanay Ofran | Director |
| Micah Pearlman | Executive |
| Leo J. Redmond | Executive |
| Mace Rothenberg | Director |
| James Vasselli | Executive |
| Joseph Yanchik | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
700 Larkspur Landing Cir Ste 108
Larkspur, CA, 94939
Larkspur, CA, 94939